JP2023517660A5 - - Google Patents
Info
- Publication number
- JP2023517660A5 JP2023517660A5 JP2022554748A JP2022554748A JP2023517660A5 JP 2023517660 A5 JP2023517660 A5 JP 2023517660A5 JP 2022554748 A JP2022554748 A JP 2022554748A JP 2022554748 A JP2022554748 A JP 2022554748A JP 2023517660 A5 JP2023517660 A5 JP 2023517660A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence number
- constant region
- fragment
- isolated protein
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062989071P | 2020-03-13 | 2020-03-13 | |
| US202062989187P | 2020-03-13 | 2020-03-13 | |
| US202062989230P | 2020-03-13 | 2020-03-13 | |
| US202062989120P | 2020-03-13 | 2020-03-13 | |
| US202062989093P | 2020-03-13 | 2020-03-13 | |
| US62/989,187 | 2020-03-13 | ||
| US62/989,120 | 2020-03-13 | ||
| US62/989,093 | 2020-03-13 | ||
| US62/989,230 | 2020-03-13 | ||
| US62/989,071 | 2020-03-13 | ||
| PCT/IB2021/052121 WO2021181366A1 (en) | 2020-03-13 | 2021-03-15 | Materials and methods for binding siglec-3/cd33 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023517660A JP2023517660A (ja) | 2023-04-26 |
| JP2023517660A5 true JP2023517660A5 (cg-RX-API-DMAC7.html) | 2024-03-19 |
Family
ID=75108687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554748A Pending JP2023517660A (ja) | 2020-03-13 | 2021-03-15 | シグレック3/cd33に結合させるための材料及び方法 |
Country Status (20)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7686571B2 (ja) | 2019-05-08 | 2025-06-02 | ヤンセン バイオテツク,インコーポレーテツド | T細胞媒介性免疫を調節するための材料及び方法 |
| CA3173268A1 (en) * | 2020-02-27 | 2021-09-02 | Janssen Biotech, Inc. | Materials and methods for modulating an immune response |
| KR20240055002A (ko) * | 2021-09-13 | 2024-04-26 | 얀센 바이오테크 인코포레이티드 | 암 치료를 위한 CD33 x Vδ2 다중특이성 항체 |
| IL312734A (en) * | 2021-11-12 | 2024-07-01 | Janssen Biotech Inc | Materials and methods for improved expansion and uses of immune cells |
| AR134580A1 (es) * | 2023-12-08 | 2026-01-28 | Janssen Biotech Inc | ANTICUERPOS DE CD33, ANTICUERPOS MULTIESPECÍFICOS DE CD33 / Vd2 Y USOS DE ESTOS |
| WO2026006719A1 (en) * | 2024-06-28 | 2026-01-02 | IN8bio, Inc. | Multifunctional molecules and methods of treatment |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US3832253A (en) | 1973-03-21 | 1974-08-27 | Baxter Laboratories Inc | Method of making an inflatable balloon catheter |
| US4667014A (en) | 1983-03-07 | 1987-05-19 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| CA1200416A (en) | 1983-05-13 | 1986-02-11 | Societe Des Produits Nestle S.A. | Food process |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6255458B1 (en) | 1990-08-29 | 2001-07-03 | Genpharm International | High affinity human antibodies and human antibodies against digoxin |
| JPH04167172A (ja) | 1990-10-31 | 1992-06-15 | Nec Corp | ベクトルプロセッサ |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| US5932448A (en) | 1991-11-29 | 1999-08-03 | Protein Design Labs., Inc. | Bispecific antibody heterodimers |
| US5635483A (en) | 1992-12-03 | 1997-06-03 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| US5780588A (en) | 1993-01-26 | 1998-07-14 | Arizona Board Of Regents | Elucidation and synthesis of selected pentapeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US6818749B1 (en) | 1998-10-31 | 2004-11-16 | The United States Of America As Represented By The Department Of Health And Human Services | Variants of humanized anti carcinoma monoclonal antibody cc49 |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| DE60131456T2 (de) | 2000-11-30 | 2008-07-10 | Medarex, Inc., Milpitas | Transchromosomale transgen-nagetiere zur herstellung von humanen antikörpern |
| US6884869B2 (en) | 2001-04-30 | 2005-04-26 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
| AU2002368077B2 (en) | 2001-07-12 | 2010-03-04 | Jefferson Foote | Super humanized antibodies |
| US6833441B2 (en) | 2001-08-01 | 2004-12-21 | Abmaxis, Inc. | Compositions and methods for generating chimeric heteromultimers |
| US20050100965A1 (en) * | 2003-11-12 | 2005-05-12 | Tariq Ghayur | IL-18 binding proteins |
| KR101374454B1 (ko) | 2005-03-31 | 2014-03-17 | 추가이 세이야쿠 가부시키가이샤 | 회합제어에 의한 폴리펩티드 제조방법 |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| DK1999154T3 (da) | 2006-03-24 | 2012-12-03 | Merck Patent Gmbh | Fremstillede heterodimere proteindomæner |
| WO2007147901A1 (en) | 2006-06-22 | 2007-12-27 | Novo Nordisk A/S | Production of bispecific antibodies |
| ES2390611T3 (es) | 2006-12-18 | 2012-11-14 | Arigen Pharmaceuticals, Inc. | Agente de erradicación de Helicobacter pylori que tiene actividad inhibidora sobre la secreción de ácido gástrico |
| US8748356B2 (en) | 2007-10-19 | 2014-06-10 | Janssen Biotech, Inc. | Methods for use in human-adapting monoclonal antibodies |
| AU2008343589A1 (en) | 2007-12-19 | 2009-07-09 | Centocor Ortho Biotech Inc. | Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods |
| EP2282769A4 (en) | 2008-04-29 | 2012-04-25 | Abbott Lab | DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND ITS USES |
| US8093018B2 (en) * | 2008-05-20 | 2012-01-10 | Otsuka Pharmaceutical Co., Ltd. | Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same |
| JP2012505654A (ja) | 2008-10-14 | 2012-03-08 | ヤンセン バイオテツク,インコーポレーテツド | 抗体をヒト化及び親和性成熟する方法 |
| US9067986B2 (en) | 2009-04-27 | 2015-06-30 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| PT2560993T (pt) | 2010-04-20 | 2024-09-16 | Genmab As | Proteínas contendo anticorpo heterodimérico fc e métodos para a produção das mesmas |
| WO2011143545A1 (en) | 2010-05-14 | 2011-11-17 | Rinat Neuroscience Corporation | Heterodimeric proteins and methods for producing and purifying them |
| EP2420253A1 (en) | 2010-08-20 | 2012-02-22 | Leadartis, S.L. | Engineering multifunctional and multivalent molecules with collagen XV trimerization domain |
| CN103429620B (zh) | 2010-11-05 | 2018-03-06 | 酵活有限公司 | 在Fc结构域中具有突变的稳定异源二聚的抗体设计 |
| IN2014CN03887A (cg-RX-API-DMAC7.html) | 2011-10-27 | 2015-10-16 | Genmab As | |
| US9574010B2 (en) | 2011-11-04 | 2017-02-21 | Zymeworks Inc. | Stable heterodimeric antibody design with mutations in the Fc domain |
| US9527927B2 (en) | 2011-12-20 | 2016-12-27 | Medimmune, Llc | Modified polypeptides for bispecific antibody scaffolds |
| WO2013157953A1 (en) | 2012-04-20 | 2013-10-24 | Merus B.V. | Methods and means for the production of ig-like molecules |
| PT2970980T (pt) | 2013-03-15 | 2018-11-19 | Janssen Biotech Inc | Métodos de produção para controlor o teor de lisina c-terminal, galactose e ácido siálico em proteínas recombinantes |
| DK3189081T3 (da) | 2014-09-05 | 2020-05-04 | Janssen Pharmaceutica Nv | Cd123-bindende midler og anvendelser deraf |
| TWI773646B (zh) * | 2015-06-08 | 2022-08-11 | 美商宏觀基因股份有限公司 | 結合lag-3的分子和其使用方法 |
| EP3307779A2 (en) * | 2015-06-12 | 2018-04-18 | Alector LLC | Anti-cd33 antibodies and methods of use thereof |
| CN109843926B (zh) | 2016-09-30 | 2023-01-20 | 豪夫迈·罗氏有限公司 | 针对cd3的双特异性抗体 |
| GB201709203D0 (en) * | 2017-06-09 | 2017-07-26 | Autolus Ltd | Antigen-binding domain |
| EP3684816B1 (en) | 2017-09-22 | 2024-05-29 | Kite Pharma, Inc. | Chimeric polypeptides and uses thereof |
| JP2021506842A (ja) | 2017-12-18 | 2021-02-22 | ヤンセン バイオテツク,インコーポレーテツド | ポリペプチドの放射性標識 |
| JOP20190116A1 (ar) * | 2018-05-24 | 2019-11-24 | Janssen Biotech Inc | الأجسام المضادة لتكتل التمايز 33 (cd33)، والأجسام المضادة ثنائية النوعية لتكتل التمايز 33 (cd33)/تكتل التمايز 3 (cd3) واستخداماتها |
-
2021
- 2021-03-15 PE PE2023001651A patent/PE20231517A1/es unknown
- 2021-03-15 AU AU2021235564A patent/AU2021235564A1/en active Pending
- 2021-03-15 IL IL302347A patent/IL302347A/en unknown
- 2021-03-15 EP EP23160422.4A patent/EP4233893A3/en not_active Withdrawn
- 2021-03-15 KR KR1020237011667A patent/KR20230051615A/ko active Pending
- 2021-03-15 UY UY0001040280A patent/UY40280A/es unknown
- 2021-03-15 IL IL302349A patent/IL302349A/en unknown
- 2021-03-15 KR KR1020227035280A patent/KR20220154728A/ko not_active Withdrawn
- 2021-03-15 PE PE2022001955A patent/PE20230001A1/es unknown
- 2021-03-15 UY UY0001039130A patent/UY39130A/es unknown
- 2021-03-15 US US17/906,040 patent/US20240293453A1/en active Pending
- 2021-03-15 KR KR1020237011668A patent/KR20230051616A/ko active Pending
- 2021-03-15 JP JP2022554748A patent/JP2023517660A/ja active Pending
- 2021-03-15 BR BR112022018176A patent/BR112022018176A2/pt unknown
- 2021-03-15 MX MX2022011320A patent/MX2022011320A/es unknown
- 2021-03-15 WO PCT/IB2021/052121 patent/WO2021181366A1/en not_active Ceased
- 2021-03-15 CA CA3171113A patent/CA3171113A1/en active Pending
- 2021-03-15 KR KR1020237011669A patent/KR20230051617A/ko active Pending
- 2021-03-15 IL IL302351A patent/IL302351A/en unknown
- 2021-03-15 UY UY0001040278A patent/UY40278A/es unknown
- 2021-03-15 PE PE2023001668A patent/PE20240020A1/es unknown
- 2021-03-15 EP EP23160439.8A patent/EP4233895A3/en not_active Withdrawn
- 2021-03-15 PE PE2023001646A patent/PE20240019A1/es unknown
- 2021-03-15 EP EP21713138.2A patent/EP4117715A1/en active Pending
- 2021-03-15 PH PH1/2022/552370A patent/PH12022552370A1/en unknown
- 2021-03-15 TW TW110109226A patent/TW202144418A/zh unknown
- 2021-03-15 IL IL296263A patent/IL296263A/en unknown
- 2021-03-15 EP EP23160428.1A patent/EP4233894A3/en not_active Withdrawn
- 2021-03-15 UY UY0001040279A patent/UY40279A/es unknown
- 2021-03-15 CN CN202180020162.XA patent/CN115768482A/zh active Pending
-
2022
- 2022-09-12 CL CL2022002488A patent/CL2022002488A1/es unknown
- 2022-09-13 EC ECSENADI202271278A patent/ECSP22071278A/es unknown
- 2022-09-13 JO JOP/2022/0220A patent/JOP20220220A1/ar unknown
- 2022-09-27 CO CONC2022/0013823A patent/CO2022013823A2/es unknown
-
2023
- 2023-03-29 CL CL2023000911A patent/CL2023000911A1/es unknown
- 2023-03-29 CL CL2023000910A patent/CL2023000910A1/es unknown
- 2023-03-29 CL CL2023000909A patent/CL2023000909A1/es unknown
- 2023-04-26 AU AU2023202520A patent/AU2023202520A1/en not_active Abandoned
- 2023-04-26 US US18/307,076 patent/US20230365683A1/en active Pending
- 2023-04-26 US US18/307,127 patent/US20230365684A1/en active Pending
- 2023-04-26 US US18/307,146 patent/US20230250171A1/en active Pending
- 2023-04-27 AU AU2023202538A patent/AU2023202538A1/en not_active Abandoned
- 2023-04-27 AU AU2023202536A patent/AU2023202536A1/en not_active Abandoned
- 2023-04-27 AR ARP230101028A patent/AR129169A2/es unknown
- 2023-04-27 AR ARP230101026A patent/AR129167A2/es unknown
- 2023-04-27 AR ARP230101027A patent/AR129168A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11202828B2 (en) | Therapeutic SIRP-α antibodies | |
| EP3180363B1 (en) | Sirp-alpha immunoglobulin fusion proteins | |
| CN108976300B (zh) | Pd-1结合分子和其使用方法 | |
| JP6633032B2 (ja) | Tigitに対する抗体 | |
| US20210214440A1 (en) | Materials and methods for in vivo biological targeting | |
| TW202208429A (zh) | 用於治療多發性骨髓瘤之方法 | |
| CA3020864A1 (en) | Novel b7-h3-binding molecules, antibody drug conjugates thereof and methods of use thereof | |
| TW201702265A (zh) | 結合lag-3的分子和其使用方法 | |
| TWI814715B (zh) | Adam9結合分子及使用其的方法 | |
| TWI814758B (zh) | 雙特異性cd16-結合分子及其在疾病治療中的用途 | |
| US20230279108A1 (en) | Therapeutic sirp-alpha antibodies | |
| JP2025508692A (ja) | 免疫複合体及びその使用 | |
| US20240336686A1 (en) | Novel multi-specific molecules | |
| WO2025085857A1 (en) | Sirp antibodies for treatment of cancer | |
| WO2024102948A1 (en) | Fc receptor-homolog 5 (fcrh5) specific binding molecules and bispecific t-cell engaging antibodies including same and related methods | |
| WO2024010861A2 (en) | Methods and compositions for treating autoimmune, allergic and inflammatory diseases | |
| KR20240052030A (ko) | 높은 열 안정성 및 감쇠된 효과기 기능을 갖는 fc 변이체 | |
| Strohl | Isotype selection and Fc engineering: design and construction of fit-for-purpose therapeutic antibodies | |
| EA052211B1 (ru) | ВАРИАНТ Fc С ВЫСОКОЙ ТЕРМОСТАБИЛЬНОСТЬЮ И ОСЛАБЛЕННОЙ ЭФФЕКТОРНОЙ ФУНКЦИЕЙ | |
| JP2024508764A5 (cg-RX-API-DMAC7.html) | ||
| HK1237789A1 (en) | Sirp-alpha immunoglobulin fusion proteins | |
| HK1237789B (en) | Sirp-alpha immunoglobulin fusion proteins |